|
|
|
|
||
Re: This article contribute to today's decline? No: about how to label biosimilarsThis article is about how to label biosimilars vs original protein therapeutics so physicians and pharmacists can identify them more easily and avoid unauthorized switching. Favors avoiding switching from original protein therapeutics to biosimilars. |
return to message board, top of board |